Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Etripamil

🥰Excellent
Catalog No. T15257Cas No. 1593673-23-4
Alias MSP-2017, (-)-MSP-2017

Etripamil (MSP-2017) displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel. It has a rapid onset of action designed for intranasal administration. It is also used to treat Paroxysmal Supraventricular Tachycardia.

Etripamil

Etripamil

🥰Excellent
Purity: 99.83%
Catalog No. T15257Alias MSP-2017, (-)-MSP-2017Cas No. 1593673-23-4
Etripamil (MSP-2017) displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel. It has a rapid onset of action designed for intranasal administration. It is also used to treat Paroxysmal Supraventricular Tachycardia.
Pack SizePriceAvailabilityQuantity
1 mg$74In Stock
5 mg$179In Stock
10 mg$289In Stock
25 mg$579In Stock
50 mg$868In Stock
100 mg$1,180In Stock
500 mg$2,380In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Etripamil"

Select Batch
Purity:99.83%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Etripamil (MSP-2017) displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel. It has a rapid onset of action designed for intranasal administration. It is also used to treat Paroxysmal Supraventricular Tachycardia.
In vitro
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells.
AliasMSP-2017, (-)-MSP-2017
Chemical Properties
Molecular Weight452.59
FormulaC27H36N2O4
Cas No.1593673-23-4
SmilesCOC(=O)c1cccc(CCN(C)CCC[C@](C#N)(C(C)C)c2ccc(OC)c(OC)c2)c1
Relative Density.1.079 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 110 mg/mL (243.05 mM), Sonication is recommended.
Solution Preparation Table
Ethanol
1mg5mg10mg50mg
1 mM2.2095 mL11.0475 mL22.0951 mL110.4753 mL
5 mM0.4419 mL2.2095 mL4.4190 mL22.0951 mL
10 mM0.2210 mL1.1048 mL2.2095 mL11.0475 mL
20 mM0.1105 mL0.5524 mL1.1048 mL5.5238 mL
50 mM0.0442 mL0.2210 mL0.4419 mL2.2095 mL
100 mM0.0221 mL0.1105 mL0.2210 mL1.1048 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Etripamil | purchase Etripamil | Etripamil cost | order Etripamil | Etripamil chemical structure | Etripamil in vitro | Etripamil formula | Etripamil molecular weight